✨ Your Portfolio is fetched and updated from zerodha.
Small Chemicals
Market Cap
₹1,964 Cr.
P/E
0.00
  • Astec Lifesciences
  • Punjab Chem. & Corp
  • Excel Industries
FAQs on Astec Lifesciences Ltd. Shareprice

Astec Lifesciences has given lower returns compared to its competitors.
Astec Lifesciences has grown at ~-21.93% over the last 3yrs while peers have grown at a median rate of -9.35%

Astec Lifesciences is not expensive.
Latest PE of Astec Lifesciences is 0.0, while 3 year average PE is 50.55.
Also latest EV/EBITDA of Astec Lifesciences is 0.0 while 3yr average is 26.88.

Growth Table
  • Astec Lifesciences Ltd.
  • Punjab Chem. & Corp
  • Excel Industries
Balance Sheet
  • Astec Lifesciences Ltd.
  • Punjab Chem. & Corp
  • Excel Industries
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Astec Lifesciences Ltd.
  • Punjab Chem. & Corp
  • Excel Industries
Cash Flow
  • Astec Lifesciences Ltd.
  • Punjab Chem. & Corp
  • Excel Industries
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Astec Lifesciences Ltd.
  • Punjab Chem. & Corp
  • Excel Industries
Quarterly Results
  • Astec Lifesciences Ltd.
  • Punjab Chem. & Corp
  • Excel Industries
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Astec Lifesciences Ltd. Financials

Balance sheet of Astec Lifesciences is moderately strong, But short term working capital might become an issue for this company.

Yes, The net debt of Astec Lifesciences is increasing.
Latest net debt of Astec Lifesciences is ₹549 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹489 Crs.

The profit is oscillating.
The profit of Astec Lifesciences is -₹128.03 Crs for TTM, -₹134.75 Crs for Mar 2025 and -₹46.93 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Astec Lifesciences latest dividend payout ratio is 11.5% and 3yr average dividend payout ratio is 11.5%

Companies resources are majorly tied in miscellaneous assets

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech